BGEM ® Glucose Range represents a major advancement in non-invasive glucose evaluation. Credit: Actxa Actxa, a Singapore-based preventive health technology company, recently announced significant enhancements to its proprietary BGEM ® technology, the world's first clinically backed, non-invasive, AI-driven blood glucose evaluation and monitoring technology. The advancements strengthen BGEM ® 's ability to deliver medical-grade glucose insights through everyday wearables. One key innovation...